Facebook Linkedin Twitter
Inside Precision Medicine Tevogen Bio to Develop Predictive T Cell Technology with Microsoft

Johnson & Johnson

Digital Brain hovering above a series of computer chips to illustrate artificial intelligence (AI)-powered tools to help Tevogen Bio develop new T cell therapies
Coronavirus

Tevogen Bio to Develop Predictive T Cell Technology with Microsoft

0
The Importance of Increasing Diversity in Clinical Trials
News & Features

The Importance of Increasing Diversity in Clinical Trials

Larissa Warneck-Silvestrin
0
DNA Molecular Structure
News & Features

Merck Inks $1B Synthetic Biology Deal with Pearl

0
Antibody drug conjugated with cytotoxic payload. Synthetic Biology
News & Features

Johnson & Johnson to Acquire Clinical-Stage Antibody Drug Conjugate Company Ambrx for $2 Billion

0
Illustration of several SARS-CoV-2 virus particles in blue on a red background
Coronavirus

COVID Vaccine Booster via Inhaler Ups Protection in Monkeys

0
Artificial intelligence DNA
News & Features

“Ground-Breaking” Release of World’s Largest Whole Genome Resource

0
Cancer Gene
Molecular Dx

Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching

0
3D rendering representing interaction between brain neurons
News & Features

Neurological Precision Therapy Company Rapport Therapeutics Launches with $100 Million Series A

0
Different family types seamless pattern
Molecular Dx

U.K.’s Our Future Health Aims to Transform Disease Prevention, Detection, Treatment

0
Portrait of doctor in emergency care unit of a hospital holding bag valve mask
Coronavirus

Vaccinated Cancer Patients with Breakthrough COVID-19 Infections Have High Death Rates

0
123Page 1 of 3

Related Content

Sage Publishing

Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.
Terms of ServicePrivacy Policy

Sage Publishing
Inside Precision Medicine